Results 101 to 110 of about 9,946,516 (158)

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. [PDF]

open access: yesCommun Biol
Huang CY   +8 more
europepmc   +1 more source

Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient

open access: yesJournal of the European Academy of Dermatology and Venereology, 2010
P. Fava   +3 more
semanticscholar   +1 more source

Long non-coding RNA H19 as a prognostic biomarker for oral squamous cell carcinoma. [PDF]

open access: yesFront Med (Lausanne)
Kumar K   +8 more
europepmc   +1 more source

Clinical Heterogeneity Associated with MYO7A Variants Relies on Affected Domains. [PDF]

open access: yesBiomedicines, 2022
Joo SY   +11 more
europepmc   +1 more source

A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia.

open access: yesBlood, 2004
Y. Soda   +17 more
semanticscholar   +1 more source

Clinical significance of Beta-2 glycoprotein I antibodies in BcrAbl (-) myeloproliferative neoplasms

open access: yes, 2017
Background: Beta-2 glycoprotein I antibodies (B2-GPI Ab) are significant markers of thrombosis in otoimmune diseases. No literature has been found in Bcr Abl (-) MPNs to exclude the risk of hereditary thrombophilia and to investigate the association of ...
Unlu, Ali   +2 more
core  

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells. [PDF]

open access: yesHaematologica, 2017
Wang J   +8 more
europepmc   +1 more source

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors. [PDF]

open access: yesInt J Mol Sci, 2020
Pouloudi D   +6 more
europepmc   +1 more source

Cross‐resistance of imatinib mesylate and 17‐aag in imatinib‐resistant cells that overexpress bcr‐abl

open access: yesBritish Journal of Haematology, 2003
J. Topaly   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy